Anton Peleg is Professor of Infectious Diseases and Microbiology and Director of the Department of Infectious Diseases at the Alfred Hospital and Monash University. He is also a research group leader in the Department of Microbiology, Monash University. His research spans clinical to basic research, with a focus on hospital-acquired infections, antimicrobial resistance, infections in immunocompromised hosts and understanding mechanisms of disease caused by hospital pathogens. He has a particular clinical interest in complex infections in highly vulnerable patient groups, including patients with cystic fibrosis, lung and stem cell transplant recipients, and infections in patients with burns or in intensive care.Top
Denis Spelman is an Infectious Diseases Physician and Medical Microbiologist. He is currently the Deputy Director of the Clinical Infectious Diseases Unit and Head of the Microbiology Department. He is the Head of the Spleen Registry and has an interest in infection control, multi resistant organisms and their management.Top
Jennifer Hoy is the Director of HIV Medicine at the Alfred Hospital and Professor of Medicine at Monash University. She was Head of the Clinical Research Unit in Infectious Diseases for 20 years and has extensive clinical trial and research experience. She is currently a member of the ASHM ARV Guidelines Panel, as well as Editor of the ASHM monograph, Managing HIV infection in Australasia. Her current research interests include the serious non-AIDS complications of HIV infection and its treatment with combination ART, including cardiovascular disease and bone disease.Top
Dr Julian Elliott is Head of Clinical Research at the Alfred Hospital Infectious Diseases Unit and HIV Clinical Advisor, Centre for Population Health, Burnet Institute. His research interests are in the use of antiretroviral therapy in low- and middle-income countries, including treatment monitoring and failure and immune restoration disease. He was previously Technical Advisor in HIV treatment, care and research at the National Center in HIV/AIDS, Dermatology and STDs (NCHADS) of the Cambodian Ministry of Health, on secondment from the National Centre in HIV Epidemiology and Clinical Research (NCHECR) at the University of New South Wales. In that position he contributed to the rapid expansion of HIV care in Cambodia and the establishment of an HIV research program. Dr Elliott trained as an infectious diseases physician and has worked in health care programs in other countries in South-east Asia and in Australian Aboriginal communities. He has been a member of various Cambodian national HIV policy committees, international program committees of Oxfam Australia and Australian aboriginal health working groups.Top
Allen Cheng is Associate Professor in Infectious Disease Epidemiology at Monash University and Deputy Head of the Infection Prevention and Healthcare Epidemiology Unit at Alfred Health. He is an infectious diseases physician and has worked in Papua New Guinea, regional and remote Australia, the United States, Thailand and Finland. He is a member of the Australian Committee on Prescription Medicines and a committee member on the Clinical Research Network and the Clinical Guidelines Committee of the Australasian Society for Infectious Diseases. His research interests include the prevention of hospital infections and resistant bacteria, influenza surveillance, clinical infectious diseases, biostatistics and the management of severe sepsis in developing countries.
Dr Andrew Fuller is an Infectious Diseases Physician and microbiologist and has been at the Alfred Hospital as a fulltime staff specialist for almost twenty years. Dr Fuller began the ‘Hospital in the Home' program in 1995 and has been managing the program as medical head since that time. The Alfred Hospital program is currently the largest ‘Hospital in the Home' program in Victoria managing a wide range of complicated patients and conditions.
Dr Fuller's interests are in a wide range of Infectious Diseases ranging from tropical medicine, hospital infections and transplant infections through to orthopaedic infections.Top
Olga Vujovic is an Infectious Diseases Physician at The Alfred in Melbourne. She has been involved in HIV clinical care for over ten years and with the Victorian HIV Consultancy since 2003. Her interests are in complex care and chronic disease, the development of new models of care as the HIV epidemic continues to evolve and innovative education programs for health care workers in the field of HIV medicine.Top
Paul Cameron is a clinical immunologist and immunopathologist with research interests in pathogenesis of HIV infection and immunodeficiency syndromes. He has appointments with Pathology department, Allergy Immunology and Respiratory medicine and the Infectious Diseases Unit at the Alfred Hospital and an academic appointment with Immunology Department at Monash University. He is co-head of lab with Prof Sharon Lewin and has grant funding to study mechanisms controlling latent HIV infection in resting T cells and drug adverse events.Top
Dr. Orla Morrissey was awarded with honours, bachelor degrees in Medicine and Surgery in 1992 from University College Cork, National University of Ireland. She did her basic physician training at St. Vincent's Hospital, Melbourne and her advanced training in Infectious Diseases at the Alfred Hospital, Melbourne, which resulted in the award of Fellowship of the Royal Australasian College of Physicians in 2002. Dr. Morrissey was also awarded a Graduate Diploma in Clinical Epidemiology in 2005. In 2009 she was awarded a Ph.D for her research into the development of new antifungal strategies for the management of invasive aspergillosis.
Dr. Orla Morrissey was appointed in April 2009 to develop and lead an innovative Consult Service for the Immunocompromised Host within the Infectious Diseases Unit, Alfred Hospital and as Adjunct Senior Lecturer in the Departments of Medicine and Clinical Haematology, Monash University.
Dr. Orla Morrissey also leads a clinical- and laboratory-based research program examining pre-emptive treatment strategies for invasive aspergillosis, different prophylactic regimens for invasive fungal infections (IFI), new surveillance strategies, trends in antifungal resistance, molecular epidemiology and host- and pathogen-related risk factors for IFI. She is involved in a number of national and international studies in collaboration with Australia and New Zealand Mycology Interest Group (ANZMIG), Australasian Leukaemia Lymphoma Group, European Organization for Research and Treatment of Cancer and the NIH-funded Aspergillus Technical Expert Committee. She has received over AU$2.5M in NHMRC, Cancer Council and industry funding, is on the steering committee for 3 PhD students and has supervised 1 Advanced Medical Science student. She was recently appointed as a member of the Independent Review Committee for an international multicentre trial examining the efficacy and safety of liposomal amphotericin B as antifungal prophylaxis in patients undergoing chemotherapy for acute lymphoblastic leukaemia.
Dr. Morrissey is the current co-chair of Australia and New Zealand Mycology Interest Group (ANZMIG) and a member of the Australasian Society of Infectious Diseases, Australian Society of HIV Medicine and the American Society of Microbiology. She was also the co-chair of the National Working Party to develop evidence based Australasian guidelines for the management of IFI in haematology patients and a member of the Steering Committee for the development of Australasian consensus guidelines for the management of febrile neutropenia in haematology/oncology patients. Dr. Morrissey has been invited to speak at 4 international conferences and 9 national conferences and was invited to chair the ANZMIG Symposium at the Australasian Society of Infectious Diseases Annual Scientific Meeting in 2005, 2008 & 2009. She has 18 peer reviewed publications, 28 national and international conference abstracts and 1 co-authored book chapter. She is a regular reviewer for Mycoses Journal and the Internal Medicine Journal.Top
Sharon Lewin is a visiting infectious diseases physician and basic scientist. She is Director Peter Doherty Institute Melbourne University and Royal Melbourne Hospital, she was the previous Professor/Director of the Department of Infectious Diseases at The Alfred and Monash University. She is an NHMRC Practitioner Fellow. She completed her medical training at Monash University, followed by a PhD in virology at the Burnet Institute in Melbourne and a post-doctoral fellowship at the Aaron Diamond AIDS Research Center, The Rockefeller University in New York. She has received continuous research funding from the NHMRC since 1993 and funding from the National Institutes for Health, the Wellcome Trust and the American Foundation for AIDS Research. She heads a research laboratory that aims to understand why HIV and hepatitis B virus persist and evade the immune system.Top